Knight Therapeutics | GUD - 销售收入

股票价格

7.50

每天变化

0.05 0.67%

每月一次

1.21%

每年

22.35%

Q2 预测

7.39

金融业

CAD

CAD 1.05B

现金及等价物

CAD 76.45M

CAD 82.22M

CAD 394.84M

CAD 165.26M

CAD 77.91M

CAD 6.21M

CAD 24.45M

698

EPS每股收益

CAD -0.09

股本和储备

CAD 767.27M

CAD 64.72M

债务利息支出

CAD 3.92M

CAD 2.46M

CAD 57.78M

CAD 754.73M

CAD -3.79M

CAD 126.9M

CAD 6.21M

普通股股本

CAD 99.68M

257.34

CAD -1.92M

CAD 133.11M

销售和管理费用

CAD 35.45M

CAD 95.4M

贸易债权人

CAD 125.76M

应收帐款人

CAD 183M

	销售	更改		日
Acasti Pharma	USD -4.76M		4.76M	2024-12
Akebia Therapeutics	USD 57.62M		1.14M	2025-12
Alaunos Therapeutics	USD 2K		2K	2025-03
Aurora Cannabis	CAD 94.19M		3.82M	2025-12
Avita Medical	AUD 17.61M		805K	2025-12
Canopy Growth	CAD 74.54M		7.86M	2025-12
Cronos Group	USD 58.39M		22.05M	2025-12
Dianthus Therapeutics	USD 284K		112K	2025-12
Ionis Pharmaceuticals	USD 246M		43M	2026-03
IQVIA Holdings	USD 4.36B		260M	2025-12
Knight Therapeutics	CAD 133.11M		11.56M	2025-12
Moderna	USD 678M		342M	2025-12
Organigram Holdings	CAD 63.54M		16.52M	2025-12
Organon & Co	USD 1.46B		50M	2026-03
Revvity	USD 772.06M		73.06M	2025-12
Tectonic Therapeutic	USD 0		0	2024-12
Tilray	USD 217.51M		74.75M	2025-12
Viatris	USD 3.7B		60M	2025-12
Xeris Pharmaceuticals	USD 85.81M		11.43M	2025-12